Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
2021 | 75 | 5 | 44-51

Article title

A new therapeutic option in the management of allergic rhinitis

Content

Title variants

Languages of publication

Abstracts

EN
Allergic rhinitis (AR) affects both the quality of life and daily functioning of a patient. Carefully selected personalized therapy determines good management of disease symptoms. In the latest update of the ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines, the algorithm for therapeutic management is based on the assessment of a patient’s condition with the use of a Visual Analogue Scale (VAS), therefore adopting an approach which involves either escalation (step up) or reduction (step down) of treatment. First-line drugs include: second-generation antihistamines, intranasal corticosteroids (INCS) and a combination of INCS with azelastine. Since the combination of INCS with intranasal H1 antihistamine drugs allows patients to benefit from therapeutic advantages of both drug categories, it is considered to be a universal treatment strategy. The combination of mometasone furoate with olopatadine hydrochloride is the latest therapeutic option in this drug category. These drugs prove highly effective and demonstrate a favorable safety profile.

Year

Volume

75

Issue

5

Pages

44-51

Physical description

Dates

published
2021

Contributors

  • Department of Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland
  • Department of Otolaryngology and Laryngological Oncology with the Division of Cranio-Maxillo-Facial Surgery, Military Institute of Medicine, Warsaw, Poland

References

Document Type

Publication order reference

Identifiers

Biblioteka Nauki
23203220

YADDA identifier

bwmeta1.element.ojs-doi-10_5604_01_3001_0015_4556
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.